The Oslo Patient: A Reported HIV Cure After Stem Cell Transplant
The Oslo HIV patient cured after stem cell transplantation with the CCR5Δ32 mutation. This success opens up new research directions in the treatment of HIV.

On this page
The Oslo HIV patient cured is becoming one of the most discussed topics in the global medical community. This special case not only brings hope to millions living with HIV but also opens up new research directions in the treatment and control of the HIV virus in the future.
According to recent scientific data, the Oslo HIV patient cured after undergoing a special stem cell transplantation to treat blood cancer. Although this method cannot yet be widely applied, it is considered a significant milestone in the journey to find a complete solution for treating HIV.
Who is the Oslo patient?
The Oslo patient is a 63-year-old man in Norway, diagnosed with HIV in 2006. Several years later, he was found to have myelodysplastic syndrome—a type of blood cancer requiring stem cell transplantation. In 2020, doctors decided to perform a stem cell transplant to treat the cancer. The stem cell donor was his biological brother, and this was the key factor in the historic turning point in his treatment.
A multi-year treatment journey
Key milestones in the treatment process include:
| Time | Event |
|---|---|
| 2006 | Diagnosed with HIV |
| 2017 | Diagnosed with blood cancer (myelodysplastic syndrome) |
| 2020 | Underwent stem cell transplantation |
| 2022 | Stopped using ARV medication |
| More than 3 years after the transplant | No HIV detected in the body |
This result has drawn particular attention from the scientific community because it is one of the very few cases confirmed to show no remaining signs of HIV after treatment.
The CCR5Δ32 mutation – the key to controlling HIV
During the donor evaluation, doctors discovered that the patient's brother had the CCR5Δ32/Δ32 genetic mutation.
This is a rare genetic mutation that can:
- Prevent HIV from entering immune cells
- Limit the virus's ability to replicate
- Create a natural protective barrier against many strains of HIV
After the stem cell transplant, the patient's immune system was gradually replaced by cells carrying the CCR5Δ32 mutation, thereby preventing the body from providing a favorable environment for HIV to survive.
Post-transplant monitoring results
After a long period of treatment and monitoring, researchers recorded:
- No HIV detected in the blood
- No HIV detected in the bone marrow
- No signs of the virus in the digestive tract
- No signs of viral reactivation after stopping ARV medication
These results are particularly significant because the bone marrow and digestive tract are considered the most difficult-to-eliminate HIV reservoirs in the body.
Why is this case special?
The Oslo HIV patient cured is considered an important milestone for several reasons:
- One of the very few confirmed cases of HIV eradication after treatment
- Used stem cells from a genetically matched relative
- The patient belongs to the over-60 age group
- The treatment results lasted for many years after stopping ARV medication
This case helps scientists better understand the mechanisms of HIV's existence and elimination in the human body.
Is stem cell transplantation a cure for HIV for everyone?
Although the results are very positive, stem cell transplantation is not currently a common treatment for HIV.
Some limitations include:
A complex procedure
Stem cell transplantation is a specialized treatment process with many risks and requires strict monitoring.
Very high cost
The cost of stem cell transplantation exceeds the affordability of most patients.
Only applicable in special cases
This method is usually only indicated for patients with severe hematological diseases such as blood cancer.
Suitable donors are very rare
The CCR5Δ32 mutation only appears in a very small percentage of the population, making it extremely difficult to find a suitable donor.
Significance for the future of HIV treatment
Although not yet widely applicable, the success of the Oslo patient brings many values to HIV research.
Data from this case is helping to develop:
- Gene editing technology
- New-generation immunotherapy
- Methods to eliminate HIV reservoirs in the body
- Strategies aimed at curing HIV
This is considered an important foundation for future advancements in modern medicine.
The role of HIV testing and early treatment

While curative methods for HIV are still under research, early HIV testing and ARV treatment remain the most effective solutions available today.
People living with HIV who follow the correct treatment regimen can:
- Maintain long-term health
- Have a life expectancy nearly equivalent to that of people not infected with HIV
- Reduce viral load to undetectable levels
- Not transmit HIV through sexual contact according to the U=U principle
Love2Test.vn encourages everyone to actively get tested for HIV regularly, especially if they have risky behaviors or belong to high-risk groups.
Conclusion
The Oslo HIV patient cured is evidence of significant progress in medicine in the fight against HIV. Although stem cell transplantation is not yet a widely applicable solution, this success has opened up many promising research directions for the future. While waiting for new treatment methods, regular HIV testing, using PrEP when necessary, and early ARV treatment remain important measures to effectively control HIV and protect long-term health.
according to GMA News, The Daily Record
Further reading
This article provides general information. For decisions about diagnosis, medicines or treatment, consult a qualified healthcare professional. Service availability and costs can change; confirm with the provider before booking. Our editorial approach
